# Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

> **NCT02152709** · PHASE3 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 1537 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** 3 dose of 10µg/0.5ml hepatitis B vaccine
- **BIOLOGICAL:** 3 dose of 5µg/0.5ml hepatitis B vaccine

## Key facts

- **NCT ID:** NCT02152709
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-10
- **Target enrollment:** 1537 (ACTUAL)
- **Last updated:** 2014-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02152709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02152709, "Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02152709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*